Original Article| Volume 17, ISSUE 2, P55-57, March 2008

Vertebrobasilar Revascularization Rates and Outcomes in the MERCI and Multi-MERCI Trials


      Mortality of 40% to 86% and good outcomes in only 13% to 21% of patients beg for treatment options for basilar occlusion. This study determined outcomes of patients with vertebrobasilar occlusion treated with mechanical embolus removal in cerebral ischemia (MERCI) retriever mechanical thrombectomy.


      Patients with vertebrobasilar occlusion in the MERCI and Multi-MERCI trials received treatment up to 8 hours after symptom onset. Recanalization was determined after retriever use and adjunctive therapy. Mortality and good outcomes, modified Rankin scale score 0-3, were determined at 90 days in patients who were recanalized and not recanalized.


      Recanalization occurred in 21 of 27 (78%) patients. Mortality was 44% and good outcomes were seen in 41%. Patients with recanalization tended to have better outcomes than those without.


      Outcomes in patients with vertebrobasilar occlusions treated with the MERCI retriever compared favorably with natural history reports and tended to be better in those patients with recanalization.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hacke W.
        • Zeumer H.
        • Ferbert A.
        • et al.
        Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.
        Stroke. 1988; 19: 1216-1222
        • Schonewille W.J.
        • Algra A.
        • Serena J.
        • et al.
        Outcome in patients with basilar artery occlusion treated conventionally.
        J Neurol Neurosurg Psychiatry. 2005; 76: 1238-1241
        • Smith W.S.
        Intra-arterial thrombolytic therapy for acute basilar occlusion: Pro.
        Stroke. 2007; 38: 701-703
        • Smith W.S.
        • Sung G.
        • Starkman S.
        • et al.
        • MERCI Trial Investigators
        Safety and efficacy of mechanical embolectomy in acute ischemic stroke.
        Stroke. 2005; 36: 1432-1440
        • Smith W.S.
        • Multi MERCI Investigators
        Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: Results of the multi mechanical embolus removal in cerebral ischemia (MERCI) trial, part I.
        AJNR Am J Neuroradiol. 2006; 27: 1177-1182
      1. Smith WS, Sung GY, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke, in press.

        • Berlis A.
        • Lutsep H.
        • Barnwell S.
        • et al.
        Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization.
        Stroke. 2004; 35: 1112-1116
        • Lindsberg P.J.
        • Mattle H.P.
        Therapy of basilar artery occlusion: A systematic analysis comparing intra-arterial and intravenous thrombolysis.
        Stroke. 2006; 37: 922-928
        • Macleod M.R.
        • Davis S.M.
        • Mitchell P.J.
        • et al.
        Results of a multicenter, randomized controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischemic stroke.
        Cerebrovasc Dis. 2005; 20: 12-17

      Linked Article

      • Correction
        Journal of Stroke and Cerebrovascular DiseasesVol. 17Issue 5
        • Preview
          Lutsep, HL. New developments in secondary stroke prevention: Impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management. J Stroke Cerebrovasc Dis 2008;17:263-267.
        • Full-Text
        • PDF